Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vasopressin: a new target for the treatment of heart failure.
Lee CR, Watkins ML, Patterson JH, Gattis W, O'connor CM, Gheorghiade M, Adams KF Jr. Lee CR, et al. Am Heart J. 2003 Jul;146(1):9-18. doi: 10.1016/S0002-8703(02)94708-3. Am Heart J. 2003. PMID: 12851603 Review.
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4).
O'Connor CM, Gattis WA, Adams KF Jr, Shah MR, Frey A, Gheorghiade M; Randomized Intravenous Tezosentan Study Investigators. O'Connor CM, et al. Among authors: gattis wa. Am Heart J. 2003 Feb;145(2 Suppl):S58-9. doi: 10.1067/mhj.2003.156. Am Heart J. 2003. PMID: 12594454 Clinical Trial. No abstract available.
Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4).
O'Connor CM, Gattis WA, Adams KF Jr, Hasselblad V, Chandler B, Frey A, Kobrin I, Rainisio M, Shah MR, Teerlink J, Gheorghiade M; Randomized Intravenous TeZosentan Study-4 Investigators. O'Connor CM, et al. Among authors: gattis wa. J Am Coll Cardiol. 2003 May 7;41(9):1452-7. doi: 10.1016/s0735-1097(03)00194-3. J Am Coll Cardiol. 2003. PMID: 12742280 Free article. Clinical Trial.
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiade M; IMPACT-HF Investigators and Coordinators. Gattis WA, et al. J Am Coll Cardiol. 2004 May 5;43(9):1534-41. doi: 10.1016/j.jacc.2003.12.040. J Am Coll Cardiol. 2004. PMID: 15120808 Free article. Clinical Trial.
58 results